Erik Rafflenbeul breaks down the FAITAVI trial, in a quick, must-watch summary.
FAITAVI is the first study comparing FFR-guided PCI with angiography-guided PCI in patients with intermediate CAD and severe symptomatic AS undergoing TAVI, FFR-guided PCI was associated with a lower rate of MACCE at 12 months of follow-up.
Learn more on PCRonline: https://www.pcronline.com/News/Whats-...
#tavi, #pci, #cad, #aorticstenosis, #europcr
コメント